Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F A Anderer

Showing results (11-20 of 86) with videos related to

Pageof 9
Sort By:
Cancer Immunology, Immunotherapy : CII|November 1, 1995
Anti-(transforming growth factor beta) antibodies with predefined specificity inhibit metastasis of highly tumorigenic human xenotransplants in nu/nu miceM Hoefer, F A Anderer
Viral Immunology|January 1, 1996
Enhancement of human NK and LAK cytotoxicity against HCMV-infected cells by rhamnogalacturonan: specificity of reactionM Steinmassl, F A Anderer
Biochimica Et Biophysica Acta|February 16, 1983
Isolation and characterization of phosphoprotein pp 105 from simian virus 40-transformed mouse fibroblastsJ Pfeifle, F A Anderer
International Archives of Allergy and Applied Immunology|January 1, 1982
Preferential induction of cell-mediated immunity by chemically modified carcinoembryonic antigenH J Staab, F A Anderer
Cancer Research|June 15, 1990
Synergistic action of a plant rhamnogalacturonan enhancing antitumor cytotoxicity of human natural killer and lymphokine-activated killer cells: chemical specificity of target cell recognitionE A Mueller, F A Anderer
Zeitschrift Fur Naturforschung. Section C, Biosciences|March 1, 1976
Differences in the lipid distribution in subcellular fractions of mouse fibroblasts derived from logarithmic and stationary growthH P Kulas, F A Anderer
Anticancer Research|November 1, 1991
Dialysable factors from human leukocyte extracts activating human NK cytotoxicity against tumor cells: identification of factor-producing leukocyte subpopulationsA C Neidlinger, F A Anderer
Clinical and Experimental Immunology|February 1, 1979
Circulating carcinoembryonic antigen immune complexes in sera of patients with carcinomata of the gastrointestinal tractK Kapsopoulou-Dominos, F A Anderer
Cancer Detection and Prevention|January 1, 1984
Immunotherapy of tumor-bearing mice with chemically modified tumor membrane fractions of two syngeneic tumor cell linesH J Staab, F A Anderer
Immunopharmacology|January 1, 1990
Chemical specificity of effector cell/tumor cell bridging by a Viscum album rhamnogalacturonan enhancing cytotoxicity of human NK cellsE A Mueller, F A Anderer
Pageof 9

Showing results (11-20 of 86) with videos related to

Sort By:
Pageof 9
Cancer Immunology, Immunotherapy : CII|November 1, 1995
Anti-(transforming growth factor beta) antibodies with predefined specificity inhibit metastasis of highly tumorigenic human xenotransplants in nu/nu miceM Hoefer, F A Anderer
Viral Immunology|January 1, 1996
Enhancement of human NK and LAK cytotoxicity against HCMV-infected cells by rhamnogalacturonan: specificity of reactionM Steinmassl, F A Anderer
Biochimica Et Biophysica Acta|February 16, 1983
Isolation and characterization of phosphoprotein pp 105 from simian virus 40-transformed mouse fibroblastsJ Pfeifle, F A Anderer
International Archives of Allergy and Applied Immunology|January 1, 1982
Preferential induction of cell-mediated immunity by chemically modified carcinoembryonic antigenH J Staab, F A Anderer
Cancer Research|June 15, 1990
Synergistic action of a plant rhamnogalacturonan enhancing antitumor cytotoxicity of human natural killer and lymphokine-activated killer cells: chemical specificity of target cell recognitionE A Mueller, F A Anderer
Zeitschrift Fur Naturforschung. Section C, Biosciences|March 1, 1976
Differences in the lipid distribution in subcellular fractions of mouse fibroblasts derived from logarithmic and stationary growthH P Kulas, F A Anderer
Anticancer Research|November 1, 1991
Dialysable factors from human leukocyte extracts activating human NK cytotoxicity against tumor cells: identification of factor-producing leukocyte subpopulationsA C Neidlinger, F A Anderer
Clinical and Experimental Immunology|February 1, 1979
Circulating carcinoembryonic antigen immune complexes in sera of patients with carcinomata of the gastrointestinal tractK Kapsopoulou-Dominos, F A Anderer
Cancer Detection and Prevention|January 1, 1984
Immunotherapy of tumor-bearing mice with chemically modified tumor membrane fractions of two syngeneic tumor cell linesH J Staab, F A Anderer
Immunopharmacology|January 1, 1990
Chemical specificity of effector cell/tumor cell bridging by a Viscum album rhamnogalacturonan enhancing cytotoxicity of human NK cellsE A Mueller, F A Anderer
Pageof 9